share_log

Sientra, Inc. (NASDAQ:SIEN) Shares Sold by Granite Point Capital Management L.P.

Sientra, Inc. (NASDAQ:SIEN) Shares Sold by Granite Point Capital Management L.P.

西恩特拉公司(納斯達克代碼:SEN)由Granite Point資本管理公司出售的股票
Financial News Live ·  2022/11/02 01:31

Granite Point Capital Management L.P. lowered its holdings in shares of Sientra, Inc. (NASDAQ:SIEN – Get Rating) by 10.0% in the second quarter, Holdings Channel reports. The firm owned 1,791,287 shares of the medical instruments supplier's stock after selling 200,000 shares during the quarter. Sientra accounts for 0.4% of Granite Point Capital Management L.P.'s investment portfolio, making the stock its 29th biggest holding. Granite Point Capital Management L.P.'s holdings in Sientra were worth $1,501,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

據控股頻道報道,花崗巖點資本管理公司第二季度將其持有的西恩特拉公司股票(納斯達克代碼:SIEN-GET評級)減持了10.0%。該公司在本季度出售了20萬股後,擁有這家醫療器械供應商的1,791,287股股票。在Granite Point Capital Management L.P.的投資組合中,Sientra佔0.4%,為其第29大持股。截至Granite Point Capital Management L.P.最近提交給美國證券交易委員會(Securities and Exchange Commission,簡稱:美國證券交易委員會)的文件,Sientra所持Sientra股份價值1,501,000美元。

Several other hedge funds also recently made changes to their positions in SIEN. Mirabella Financial Services LLP purchased a new stake in shares of Sientra during the first quarter valued at approximately $26,000. Advisor Group Holdings Inc. lifted its holdings in Sientra by 230.9% in the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier's stock worth $26,000 after purchasing an additional 8,325 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Sientra in the first quarter worth about $68,000. Stephens Inc. AR raised its holdings in Sientra by 48.1% during the 2nd quarter. Stephens Inc. AR now owns 50,775 shares of the medical instruments supplier's stock worth $43,000 after buying an additional 16,500 shares during the period. Finally, Bank of Montreal Can increased its holdings in shares of Sientra by 66.7% in the 1st quarter. Bank of Montreal Can now owns 66,589 shares of the medical instruments supplier's stock valued at $151,000 after purchasing an additional 26,649 shares during the period. Institutional investors and hedge funds own 68.40% of the company's stock.

其他幾家對衝基金最近也調整了在西安的頭寸。Mirabella Financial Services LLP在第一季度購買了Sientra的新股份,價值約2.6萬美元。Advisor Group Holdings Inc.在第一季度增持了西恩特拉230.9%的股份。Advisor Group Holdings Inc.在此期間又購買了8,325股,現在擁有11,930股這家醫療器械供應商的股票,價值26,000美元。今年第一季度,康納·克拉克和倫恩投資管理有限公司(Connor Clark&Lumn Investment Management Ltd.)購入了價值約6.8萬美元的Sientra新股份。斯蒂芬斯公司在第二季度增持了西恩特拉48.1%的股份。斯蒂芬斯公司現在持有50,775股這家醫療器械供應商的股票,價值43,000美元,在此期間又購買了16,500股。最後,蒙特利爾銀行可以在第一季度增持Sientra股票66.7%。蒙特利爾銀行在此期間額外購買了26,649股,現在可以擁有66,589股這家醫療器械供應商的股票,價值15.1萬美元。機構投資者和對衝基金持有該公司68.40%的股票。

Get
到達
Sientra
西恩特拉
alerts:
警報:

Sientra Stock Performance

西門子股票表現

SIEN traded down $0.03 during mid-day trading on Tuesday, reaching $0.24. 203,286 shares of the company traded hands, compared to its average volume of 2,536,818. The company has a quick ratio of 0.77, a current ratio of 1.40 and a debt-to-equity ratio of 7.28. The stock has a market capitalization of $15.90 million, a P/E ratio of -0.30 and a beta of 1.79. Sientra, Inc. has a 52-week low of $0.20 and a 52-week high of $6.14. The company's fifty day moving average price is $0.58 and its 200-day moving average price is $0.92.

在週二午盤交易中,西安股價下跌0.03美元,至0.24美元。該公司有203,286股易手,而其平均成交量為2,536,818股。該公司的速動比率為0.77,流動比率為1.40,債務權益比為7.28。該股市值為1,590萬美元,市盈率為-0.30,貝塔係數為1.79。Sientra,Inc.的52周低點為0.20美元,52周高位為6.14美元。該公司的50日移動均線價格為0.58美元,200日移動均線價格為0.92美元。

Sientra (NASDAQ:SIEN – Get Rating) last issued its earnings results on Thursday, August 11th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.06). The company had revenue of $21.51 million for the quarter, compared to analysts' expectations of $24.05 million. Sientra had a negative return on equity of 346.56% and a negative net margin of 68.28%. On average, sell-side analysts expect that Sientra, Inc. will post -1 EPS for the current year.
西恩特拉(納斯達克:SIEN-GET評級)最近一次發佈財報是在8月11日(星期四)。這家醫療器械供應商公佈了該季度每股收益(0.29美元),低於分析師普遍預期的(0.23美元)和(0.06美元)。該公司當季營收為2,151萬美元,高於分析師預期的2,405萬美元。西門子的淨資產回報率為負346.56%,淨利潤率為負68.28%。賣方分析師平均預計,Sientra,Inc.將公佈本年度每股收益為1美元。

Wall Street Analyst Weigh In

華爾街分析師也加入進來

A number of equities research analysts have issued reports on SIEN shares. William Blair cut Sientra from an "outperform" rating to a "market perform" rating in a research report on Tuesday, October 25th. Craig Hallum decreased their price target on Sientra to $1.30 in a report on Thursday, October 27th. StockNews.com began coverage on Sientra in a research report on Friday. They set a "sell" rating on the stock. Finally, Lake Street Capital dropped their target price on Sientra from $8.00 to $2.00 in a research report on Friday, September 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $5.79.

許多股票研究分析師已經發布了關於新奧股票的報告。在10月25日星期二的一份研究報告中,威廉·布萊爾將Sientra的評級從“跑贏大盤”下調至“市場表現”。Craig Hallum在10月27日星期四的一份報告中將他們對Sientra的目標價下調至1.30美元。StockNews.com在週五的一份研究報告中開始對Sientra進行報道。他們對該股設定了“賣出”評級。最後,Lake Street Capital在9月16日星期五的一份研究報告中將其對Sientra的目標價從8.00美元下調至2.00美元。一位研究分析師對該股的評級為賣出,一位分析師對該公司股票的評級為持有,六位分析師對該公司股票的評級為買入。根據MarketBeat.com的數據,該公司的平均評級為“適度買入”,共識目標價為5.79美元。

Sientra Profile

Sientra配置文件

(Get Rating)

(獲取評級)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Sientra,Inc.是一家醫學美學公司,在美國和國際上開發和銷售醫學美學產品。該公司提供用於隆胸和乳房再造手術的硅膠乳房植入物;乳房組織擴張器;以及Sientra圓形、Sientra TearDrop、allX2、Dermaspan、SoftSpan和BIOCORNEUM品牌的疤痕處理產品。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Sientra (SIEN)
  • Online Lender SoFi Jumps 14% On Better-Than-Expected Q3 Results
  • Strong Q3 Driving Growth At S&P 500 Component Citizens Financial
  • Why American Water Works May Not Want a Fed Pivot
  • The Institutions Are Comfortable With The Furniture Industry
  • It's Still Not Too Late To Get Into Energy Stocks
  • 免費獲取StockNews.com關於Sientra的研究報告(SIEN)
  • 在線貸款機構SoFi股價上漲14%,第三季度業績好於預期
  • 強勁的第三季度推動標準普爾500指數成分股公民金融的增長
  • 為什麼美國水起作用可能不想要美聯儲的軸心
  • 這些機構對傢俱行業很滿意
  • 現在買入能源類股還不算太晚

Want to see what other hedge funds are holding SIEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sientra, Inc. (NASDAQ:SIEN – Get Rating).

想看看還有哪些對衝基金持有SIEN嗎?訪問HoldingsChannel.com獲取西恩特拉公司(納斯達克代碼:SEN-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.

接受西恩特拉日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Sientra和相關公司的最新新聞和分析師評級的每日簡明摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論